Cargando…

Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma

BACKGROUND: The rate of interval cancers is an established indicator for the performance of a cancer-screening programme. METHODS: We examined the incidence, tumour characteristics and risk factors of melanoma interval cancers that occurred in participants of the SCREEN project, which was carried ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hübner, J, Waldmann, A, Geller, A C, Weinstock, M A, Eisemann, N, Noftz, M, Bertram, S, Nolte, S, Volkmer, B, Greinert, R, Breitbart, E, Katalinic, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243984/
https://www.ncbi.nlm.nih.gov/pubmed/27898656
http://dx.doi.org/10.1038/bjc.2016.390
_version_ 1782496613769412608
author Hübner, J
Waldmann, A
Geller, A C
Weinstock, M A
Eisemann, N
Noftz, M
Bertram, S
Nolte, S
Volkmer, B
Greinert, R
Breitbart, E
Katalinic, A
author_facet Hübner, J
Waldmann, A
Geller, A C
Weinstock, M A
Eisemann, N
Noftz, M
Bertram, S
Nolte, S
Volkmer, B
Greinert, R
Breitbart, E
Katalinic, A
author_sort Hübner, J
collection PubMed
description BACKGROUND: The rate of interval cancers is an established indicator for the performance of a cancer-screening programme. METHODS: We examined the incidence, tumour characteristics and risk factors of melanoma interval cancers that occurred in participants of the SCREEN project, which was carried out 2003/2004 in Schleswig-Holstein, Germany. Data from 350 306 SCREEN participants, who had been screened negative for melanoma, were linked to data of the state cancer registry. Melanoma interval cancers were defined as melanomas diagnosed within 4–24 months after SCREEN examination. Results were compared with melanomas of the pre-SCREEN era (1999–2002), extracted from the cancer registry. RESULTS: The overall relative incidence of melanoma interval cancers in terms of observed/expected ratio was 0.93 (95% CI: 0.82–1.05; in situ: 1.61 (1.32–1.95), invasive: 0.71 (0.60–0.84)). Compared with melanomas of the pre-SCREEN era, the interval melanomas were thinner and had a slightly greater proportion of lentigo maligna melanomas whereas nodular melanomas were less frequent. INTERPRETATION: The results indicate a moderate performance of the SCREEN intervention with an excess of in situ melanomas. In part, the findings might be due to specifics of the SCREEN project, in particular a short-term follow-up of patients at high risk for melanoma.
format Online
Article
Text
id pubmed-5243984
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-52439842018-01-17 Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma Hübner, J Waldmann, A Geller, A C Weinstock, M A Eisemann, N Noftz, M Bertram, S Nolte, S Volkmer, B Greinert, R Breitbart, E Katalinic, A Br J Cancer Epidemiology BACKGROUND: The rate of interval cancers is an established indicator for the performance of a cancer-screening programme. METHODS: We examined the incidence, tumour characteristics and risk factors of melanoma interval cancers that occurred in participants of the SCREEN project, which was carried out 2003/2004 in Schleswig-Holstein, Germany. Data from 350 306 SCREEN participants, who had been screened negative for melanoma, were linked to data of the state cancer registry. Melanoma interval cancers were defined as melanomas diagnosed within 4–24 months after SCREEN examination. Results were compared with melanomas of the pre-SCREEN era (1999–2002), extracted from the cancer registry. RESULTS: The overall relative incidence of melanoma interval cancers in terms of observed/expected ratio was 0.93 (95% CI: 0.82–1.05; in situ: 1.61 (1.32–1.95), invasive: 0.71 (0.60–0.84)). Compared with melanomas of the pre-SCREEN era, the interval melanomas were thinner and had a slightly greater proportion of lentigo maligna melanomas whereas nodular melanomas were less frequent. INTERPRETATION: The results indicate a moderate performance of the SCREEN intervention with an excess of in situ melanomas. In part, the findings might be due to specifics of the SCREEN project, in particular a short-term follow-up of patients at high risk for melanoma. Nature Publishing Group 2017-01-17 2016-11-29 /pmc/articles/PMC5243984/ /pubmed/27898656 http://dx.doi.org/10.1038/bjc.2016.390 Text en Copyright © 2017 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Epidemiology
Hübner, J
Waldmann, A
Geller, A C
Weinstock, M A
Eisemann, N
Noftz, M
Bertram, S
Nolte, S
Volkmer, B
Greinert, R
Breitbart, E
Katalinic, A
Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma
title Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma
title_full Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma
title_fullStr Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma
title_full_unstemmed Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma
title_short Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma
title_sort interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243984/
https://www.ncbi.nlm.nih.gov/pubmed/27898656
http://dx.doi.org/10.1038/bjc.2016.390
work_keys_str_mv AT hubnerj intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT waldmanna intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT gellerac intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT weinstockma intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT eisemannn intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT noftzm intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT bertrams intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT noltes intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT volkmerb intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT greinertr intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT breitbarte intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma
AT katalinica intervalcancersafterskincancerscreeningincidencetumourcharacteristicsandriskfactorsforcutaneousmelanoma